Episcleritis: Difference between revisions
No edit summary |
No edit summary |
||
| Line 13: | Line 13: | ||
* Physical | * Physical | ||
** Vasodilatation of the superficial episcleral vessels | ** Vasodilatation of the superficial episcleral vessels | ||
**Focal area(s) of redness | |||
**May have a tender scleral nodule (nodular episcleritis) | |||
==Work-Up== | ==Work-Up== | ||
| Line 28: | Line 30: | ||
# Topical lubricants | # Topical lubricants | ||
## Artificial tears q4-6hr | ## Artificial tears q4-6hr | ||
#Oral NSAIDs | |||
==Disposition== | ==Disposition== | ||
Refer to ophtho to reduce chance of misdiagnosis | Refer to ophtho to reduce chance of misdiagnosis | ||
==Prognosis== | |||
Self-limiting (will resolve within 2-3 weeks) | |||
==See Also== | ==See Also== | ||
Revision as of 23:52, 30 July 2011
Background
- Abrupt onset of inflammation in the episclera
- 70% of cases occurs in women (usually young and middle-aged)
- Usually a benign, self-limited condition
- Usually not associated with an underlying disease
Diagnosis
- History
- Abrupt onset of redness, irritation, and watering of the eye
- Pain is unusual
- Vision unaffected
- 50% of cases are bilateral
- Physical
- Vasodilatation of the superficial episcleral vessels
- Focal area(s) of redness
- May have a tender scleral nodule (nodular episcleritis)
Work-Up
- Must distinguish from scleritis
- Phenylephrine drops lead to transient resolution of episcleral redness permitting evaluation of the sclera
- Must distinguish from conjunctivitis
- If the conjunctival injection is localized rather than diffuse, episcleritis is more likely
DDx
- Scleritis
- Conjunctivitis
- Herpes Keratitis
Treatment
- Topical lubricants
- Artificial tears q4-6hr
- Oral NSAIDs
Disposition
Refer to ophtho to reduce chance of misdiagnosis
Prognosis
Self-limiting (will resolve within 2-3 weeks)
See Also
Source
UpToDate